The "Cairo Accord"- Towards the Eradication of RHD: An Update

Area of Science:

• Cardiology and Global Public Health
• Pediatric and Young Adult Acquired Heart Disease

Background:

• Rheumatic heart disease (RHD) is a significant cause of acquired heart disease globally, especially in children and young adults.
• RHD disproportionately affects low- and middle-income countries, leading to substantial morbidity and mortality.
• The 2017 Cairo conference spurred the development of
• The Cairo Accord on Rheumatic Heart Disease
• to address RHD eradication.

Purpose of the Study:

• To provide an update on the recommendations outlined in the Cairo Accord on Rheumatic Heart Disease.
• To discuss recent advancements and progress in the global effort to eradicate acute rheumatic fever (ARF) and RHD.
• To highlight contributions from initiatives like the Aswan Rheumatic Heart Disease Registry (ARGI).

Main Methods:

• Review and synthesis of the Cairo Accord recommendations.
• Analysis of recent policy initiatives and calls to action for RHD eradication.
• Inclusion of data and insights from the Aswan Rheumatic Heart Disease Registry (ARGI).

Main Results:

• The Cairo Accord provides a policy framework for RHD eradication.
• Progress is being made in RHD control efforts globally.
• The ARGI contributes valuable data to understanding and combating RHD.

Conclusions:

• Continued international collaboration and policy implementation are crucial for RHD eradication.
• Sustained efforts are needed to reduce the burden of RHD in vulnerable populations.
• The Cairo Accord serves as a vital roadmap for global RHD control strategies.